Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
An AACR Special Conference on THE FUNCTION OF TUMOR MICROENVIRONMENT IN CANCER PROGRESSION January 7-10, 2016 • Hard Rock Hotel • San Diego, CA Poster Session B, Friday, January 8, 4:00 p.m.-6:00 p.m. Metabolism and Tumor Microenvironment B01 The metabolic adaptations during cancer-stroma co-evolution: The intracellular pH, NAD(P)H changes and hydrogen peroxide production in cancer cells. Irina N. Druzhkova, Marina V. Shirmanova, Maria M. Lukina, Varvara V. Dudenkova, Vsevolod V. Belousov, Sergey A. Lukiyanov, Elena V. Zagaynova. B02 Oncogene MCT-1 deregulates oxidative metabolism and promotes tumor metastasis via YY1 signaling network. Hong-Yu Tseng, Yen-An Chen, Yi-Rong Chen, Hsin-Ling Hsu. B03 Control of pancreatic cancer metabolism and histone acetylation by the tumor microenvironment. Mara H Sherman, Ronald M Evans. B04 Metabolically activated macrophages: a mechanistic link between obesity and triple-negative breast cancer? Payal Tiwari, Kelly Schoenfelt, Ariane Blank, Swati Kulkarni, Marsha Rosner, Lev Becker. B05 N-Myc downstream regulated gene 2 is a novel regulator of lipid metabolism and ubiquitinproteasome system in cancer. Libo Yao, Xia Li, Xiping Liu, Yi Ru, Mei Zhang. Therapeutic Targeting Tumor Microenvironment B06 Characterizing the effects of hypoxia and hydrostatic pressure on the expression of immunotherapeutic targets in prostate cancer cell lines and donor immune cells in culture. Bruce A Adams, James Lim, Tianna Chow , Susan Bernstein, Charles J Ryan. B07 Utilizing consomic xenograft models to identify genetic variants in the tumor microenvironment that determine breast cancer radiation responses. Carmen Bergom, Michael Straza, Amy Rymaszewski, Anne Frei, Angela Lemke, Shirng-Wern Tsaih, Howard Jacob, Michael J. Flister. B08, PR09 Antibody mediated blockade of phosphatidylserine synergizes with immune checkpoint blockade by inhibiting multiple immune suppressive mechanisms. Xianming Huang, Jian Gong, Michael Gray, Van Nguyen, Ryan Parks, Chris Hughes, Jeff Hutchins, Rolf Brekken, Bruce Freimark. B09 Ron receptor signaling promotes resistance to androgen ablation therapy in prostate cancer. Nicholas E Brown, Andrew M Paluch, Susan E Waltz. B10 Humanized anti-CD29 monoclonal antibody that inhibits multiple cancer hallmarks driven by the tumor microenvironment. Shawn Carbonell. B11 Targeting mesenchymal cells in the tumor stroma by GPX4 inhibition. Shrikanta Chattopadhyay, Cherrie Huang, Ninib Baryawno, Nicolas Severe, Vasanthi Viswanathan, Zarko Boskovic, Siddhartha Mukherjee, Jeff Gentry, Ben Wittner, Sridhar Ramaswamy, Alykhan Shamji, David Scadden, Stuart Schreiber. An AACR Special Conference on THE FUNCTION OF TUMOR MICROENVIRONMENT IN CANCER PROGRESSION January 7-10, 2016 • Hard Rock Hotel • San Diego, CA Poster Session B, Friday, January 8, 4:00 p.m.-6:00 p.m. B12 Mast cell-associated macrophage recruitment promotes gastric tumor growth. Moritz Eissmann, Andrew Jarnicki, Frederic Masson, Michael Buchert, Robert O'Donoghue, Toby Phesse, Christine Dijkstra, Michele Grimbaldeston, Matthias Ernst. B13, PR01 Disruption of DDR2-collagen interactions in tumor and stroma with a novel small molecule inhibitor blunts cancer metastasis. Whitney R Grither, Gregory D Longmore. B14 Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric adenocarcinoma. Hoon Hur, In-hye Ham, Da Keun Lee, Hye-Jin Jin, Aguilera Kristina Y. , Hae Jeong Oh, Sang-Uk Han, Ji-Eun Kwon, Young Bae Kim, Ke Ding, Rolf Brekken. B15 Targeting NOX4 in the tumor microenvironment inhibits myofibroblast differentiation and suppresses tumor progression. Christopher J Hanley, Massimiliano Mellone, Gareth J Thomas. B16 Lymphatics in triple negative breast cancer: Contribution to chemotherapeutic efficacy in vitro and in vivo. Alexandra H Harris, Jennifer M Munson. B17 Disrupting tumor growth through targeting TEM8. Anette M Høye, Sofie Tolstrup, Thomas R Cox, Jeremy P Mauldin, Arthur E Frankel, Janine T Erler. B18 CXCL10 suppresses tumor angiogenesis and impedes expression of critical angiogenic factors in renal cell carcinoma. Hyun A Jin, Jun Hyeok Heo, You Hyun Kang, Ki Hong Kim, Kyung Suk Han, Sung Joon Hong. B19 Vascular normalization suppresses tumor progression and potentiates docetaxel chemotherapy in prostate cancer. You Hyun Kang, Hyun A Jin, Jun Hyeok Heo, Ki Hong Kim, Kyung Seok Han, Sung Joon Hong. B20 Obesity-induced Nlrc4 inflammasome promotes angiogenesis in breast cancer. Ryan Kolb, Liem Phan, Nicholas Borcherding, Yinghong Liu, Fang Yuan, Ann M Janowski, Qing Xie, Kathleen R Markan, Wei Li, Matthew J Potthoff, Enrique Fuentes-Mattei, Leslie G Ellies, Michael Knudson, Mong-Hong Lee, SaiChing Jim Yeung, Suzanne L Cassel, Fayyaz S Sutterwala, Weizhou Zhang. B21 Exostosin 1 regulates cancer cell stemness in breast cancer cells. Sarala Manandhar, Chang-gu Kim, Su Young Oh, Sun-Hee Lee, Jiyoon Seok, Yuk-Dong Jung, Hye-Eun Lee, Young-Sun Choi, You Mie Lee*. B22 Necuparanib inhibits pancreatic cancer progression and invasion in a 3D tumor and stromal cell co-culture system. Amanda MacDonald, Michelle Priess, Jennifer Curran, Silva Krause. B23, PR03 Synthetic peptides suppress M2 macrophages and synergize with chemotherapy in prostate and breast cancer models. Henry Lopez, George R. Martin, Jesse M. Jaynes, Clayton Yates. B24 Targeting hyaluronan sensitizes breast cancer associated fibroblasts to lapatinib and overcomes stromal resistance. Andriy Marusyk, Doris Tabassum, Jennifer Guerriero, Andrew Place, Andrii Rozhok, Antony Letai, Kornelia Polyak. An AACR Special Conference on THE FUNCTION OF TUMOR MICROENVIRONMENT IN CANCER PROGRESSION January 7-10, 2016 • Hard Rock Hotel • San Diego, CA Poster Session B, Friday, January 8, 4:00 p.m.-6:00 p.m. B25 Characterization, targeting, and modulation of carbonic anhydrase IX activity for the development of small-molecule inhibitors to treat triple-negative breast cancer. Mam Y Mboge, Zhijuan Chen, Brian P Mahon, Nicole Lamas, Shingkuang Tu, Fabrizio Carta, Claudiu T Superan, Robert McKenna, Susan C Frost. B26 Novel pro-host role for insulin receptor substrate-1 in lung adenocarcinoma. Heather E Metz, Julia Kargl, Stephanie Busch, Kyoung-Hee Kim, McGarry Houghton. B27 Blockade of protein kinase A (PKA) localization augments the trafficking and anti-tumor efficacy of adoptively transferred chimeric antigen receptor-expressing T cells. Kheng Newick, Shaun O'Brien, Jing Sun, Veena Kapoor, Steve Maceyko, Albert Lo, Ellen Pure, Ed K Moon, Steven M Albelda. B28 NQO1 stabilizes HIF-1α by inhibiting proteasome-mediated degradation. Eun-Taex Oh, ChanWoo Kim, Heon Joo Park. B29 Interleukin-4 receptor targeted AP1-ELP-KLAK for enhancing targeted drug delivery and antitumor effect. Sarangthem Vijaya Devi, Yun Jae Kim, Yong Jin Lee, Bo-yeon Seo, Sun-ha Cheon, ByungHeon Lee, Rang-Woon Park. B30 Discovery and functional characterization of novel anti-PD-1 antibodies using ex vivo cellbased assays, single-cell immunoprofiling, and in vivo studies in humanized mice. Felix Scheuplein, Sheila Ranganath, Thomas McQuade, Lei Wang, Vikki Spaulding, Sri Vadde, Jennifer Watkins-Yoon, Bin Feng, Shanu Mehta, Maria Isabel Chiu, Cokey Nguyen. B31 Cytokine-mediated paracrine communication between pancreatic cancer and stellate cells and therapeutic applications for pancreatic ductal adenocarcinoma. Yu Shi, Tony Hunter. B32 A tumor microenvironment specific EGFR targeting antibody-drug conjugate promotes regression in KRAS or BRAF mutant tumors. Bob Veneziale, Lei Huang, Xiaoming Li, Qiping Zhao, Chunmei Zhao, Ryan Osgood, Jessica Cowell, Sanna Rosengren, Jason Parise, Ge Wei, Kim Phan, Robert Connor, Steve Rowe, Gilbert Keller, Gregory Frost, Dan Maneval, Curtis Thompson, Michael Shepard, Christopher Thanos. B34 Targeting M2-tumor associated macrophages (M2-TAMs) in prostate cancer. Jelani C Zarif, James R. Hernandez, Kenneth J Pienta. Translational Potential of the Microenvironment B35 Modeling interstitial fluid movement in the tumor microenvironment: A role in fibroblast activation? Sadhvi Nithiananthan, Aileen Crawford, Daniel W Lambert, Simon Whawell. An AACR Special Conference on THE FUNCTION OF TUMOR MICROENVIRONMENT IN CANCER PROGRESSION January 7-10, 2016 • Hard Rock Hotel • San Diego, CA Poster Session B, Friday, January 8, 4:00 p.m.-6:00 p.m. Tumor Microenvironment and Metabolic Adaptations B36 Interrogating cellular metabolism to improve therapy for EGFR mutant NSCLC. Chun-Te Chiang, Chi-Li Chiu, Cosimo Arnesano, Scott E Fraser, David B Agus, Dan L Ruderman, Shannon M Mumenthaler. B37 Targeting tumor-stroma metabolic symbiosis for head and neck cancer therapy. Dhruv Kumar, Vikalp Vishwakarma, Jacob New, Wade Gutierrez, Hemant Chavan, Partha Kasturi, Ossama Tawfik, Douglas Girod, Bennett Van Houten, George Leef, Radhika Joshi, Shary Shelton, Jeffrey Straub, Yelizaveta Shnayder, Kiran Kakarala, Terance Tsue, Fangchen Lin, Sumana Dasari, Sufi Thomas. Tumor and Stromal Cell Impact on Early Events in Carcinogenesis B38 Myeloid cells mold the microenvironment of nascent tumor and the associated immunoregulation. Mario Paolo Colombo. B39 Identifying molecular signatures of tumor dormancy as a basis for the rational design of precision nanomedicines. Galia Tiram, Shiran Ferber, Ronit Satchi-Fainaro. B40, PR07 Mechanisms of stromal reprogramming mediated by heat shock factor 1. Ruth ScherzShouval, Marc L Mendillo, Giorgio Gaglia, Irit Ben-Aharon, Andrew H. Beck, Luke Whitesell, Susan Lindquist. B41 Cell-contact dependent epithelial-stromal cross talk, including a modulation of stromal PDGFR expression, drives the progression of early stage breast cancer lesions. Carina Strell, Janna Paulsson, Artur Mezheyeuski, Shao-Bo Jin, Pernilla Roswall, Johanna Andrea, Oliver Frings, Fredrick Warnberg, Hemming Johansson, Karin Jirstrom, Kristian Pietras, Per Hall, Urban Lendahl, Christer Betsholtz, Derek C Radisky, Arne Ostman. B42 Dysregulation of key microRNAs controlling tumor-host interactions triggers escape from osteosarcoma dormancy. Galia Tiram, Paula Ofek, Taturo Udagawa, Noam Shomron, Maayan Roniger, Batsheva Kerem, Yuval Shaked, Sarit Aviel-Ronen, Iris Barshack, Marcelo Calderon, Rainer Haag, Ronit Satchi-Fainaro.